Brief: Verrica Pharmaceuticals Announces Technology Transfer Of Manufacturing Of VP-102 To Piramal Pharma Solutions
04/01/2023 12:37
Jan 4 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O :
* VERRICA PHARMACEUTICALS ANNOUNCES THE SUCCESSFUL
TECHNOLOGY
TRANSFER OF BULK SOLUTION MANUFACTURING OF VP-102 TO PIRAMAL
PHARMA SOLUTIONS
* VERRICA PHARMACEUTICALS INC - REGISTRATION STABILITY BATCH
FOR
VP-102 COMPLETED AND PLACED ON STABILITY
* VERRICA PHARMACEUTICALS INC - VERRICA REAFFIRMS ITS
EXPECTED Q1
2023 NDA RESUBMISSION FOR VP-102
Source text for Eikon: ID:nGNX2vJbtt
Further company coverage: VRCA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data